Cytoreductive surgery and heated intraperitoneal chemotherapy in relapsed epithelial ovarian cancer – Randomised control trial
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/10/059184
- Lead Sponsor
- BR Ambedkar Institute Rotary Cancer Hospital BRAIRCH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with recurrent epithelial ovarian cancer
2.Biochemical, radiological or clinical recurrence
3.Patients satisfying the selection criteria score of >6 taking into account the parameters mentioned in the following table.
ComponentsScore
Performance status03
12
Optimized 21
>20
CT PCI=83
9-122
13-151
=160
Progression free Interval >18 mo3
12-18 mo2
6-12 mo1
<6 mo0
Prior optimal CRSCC-03
CC-12
CC-21
CC-30
CA 125 at relapseNormal1
Elevated0
Symptomatic statusAsymptomatic1
Symptomatic0
Total14
Exclusion Criteria
1.Platinum resistant disease
2.Patients who have received chemotherapy after detection of recurrence
3. Extraabdominal recurrent disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method